Lung Fung Group Holdings Limited (HKG:2290)

Market Cap	1.11B
Revenue (ttm)	2.46B +21.8%
Net Income	170.43M
EPS	0.45
Shares Out	500.00M
PE Ratio	4.88
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	4,724,000
Open	2.440
Previous Close	2.440
Day's Range	2.180 - 2.440
52-Week Range	2.180 - 4.600
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About Lung Fung Group Holdings

Lung Fung Group Holdings Limited, through its subsidiaries, sells beauty, health and pharmaceutical products. It offers Chinese and western medicines, health supplements, medical supplies, beauty and skincare products, cosmetics, baby and maternity products, food, fragrances, personal care, and pet food and household daily necessities goods. The company sells its products through retail stores and online sale platforms. The company was founded in 1992 and is headquartered in Fanling, New Territories, Hong Kong. Lung Fung Group Holdings Limited ...

• Industry: Drug Stores and Proprietary Stores
• Founded: 1992
• Employees: 694
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 2290

Financial Performance

In fiscal year 2025, Lung Fung Group Holdings's revenue was 2.46 billion, an increase of 21.76% compared to the previous year's 2.02 billion. Earnings were 170.43 million, an increase of 17.92%.

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Jun 19, 2026

Data Sources Report a data error